1. Home
  2. CISO vs PASG Comparison

CISO vs PASG Comparison

Compare CISO & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CISO Global Inc.

CISO

CISO Global Inc.

HOLD

Current Price

$0.25

Market Cap

13.2M

Sector

Technology

ML Signal

HOLD

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

HOLD

Current Price

$4.57

Market Cap

15.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CISO
PASG
Founded
2015
2017
Country
United States
United States
Employees
N/A
27
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
15.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CISO
PASG
Price
$0.25
$4.57
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$14.00
AVG Volume (30 Days)
207.1K
47.0K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
79.31
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$3.29
52 Week High
$1.48
$20.00

Technical Indicators

Market Signals
Indicator
CISO
PASG
Relative Strength Index (RSI) 41.50 39.89
Support Level $0.23 $4.25
Resistance Level $0.32 $5.04
Average True Range (ATR) 0.02 0.28
MACD 0.00 0.02
Stochastic Oscillator 16.20 28.95

Price Performance

Historical Comparison
CISO
PASG

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity compliance and is a software firm composed of trained and seasoned security professionals. The services are used to protect clients' data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in the U.S., Chile, and all other countries. The maximum revenue is generated from the U.S. The products and services include: security managed services, professional services, and cybersecurity software.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: